1. Home
  2. CSTE vs GOSS Comparison

CSTE vs GOSS Comparison

Compare CSTE & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$2.98

Market Cap

76.4M

Sector

Industrials

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$10.75

Market Cap

65.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
GOSS
Founded
1987
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
65.6M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
CSTE
GOSS
Price
$2.98
$10.75
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $4.19
AVG Volume (30 Days)
53.0K
★ 4.7M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $48,471,000.00
Revenue This Year
$3.43
N/A
Revenue Next Year
$2.83
$201.64
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.56
$0.11
52 Week High
$3.84
$12.52

Technical Indicators

Market Signals
Indicator
CSTE
GOSS
Relative Strength Index (RSI) 48.75 79.61
Support Level $2.87 $0.18
Resistance Level $3.33 $12.52
Average True Range (ATR) 0.16 0.98
MACD -0.03 0.37
Stochastic Oscillator 29.05 86.51

Price Performance

Historical Comparison
CSTE
GOSS

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa), of which it derives maximum revenue from United States.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: